(Q53699940)

18 May 2018

title

Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention. (English)

1 reference

18 May 2018

0 references

0 references

8

1 reference

18 May 2018

Kogieleum Naidoo

object named as

Kogieleum Naidoo

3

0 references

Mark Hatherill

11

object named as

Mark Hatherill

1 reference

18 May 2018

10

Thomas J Scriba

1 reference

18 May 2018

Andrew Fiore-Gartland

1

1 reference

18 May 2018

Lindsay N Carpp

2

1 reference

18 May 2018

Ethan Thompson

4

1 reference

18 May 2018

Daniel E Zak

5

1 reference

18 May 2018

Steve Self

6

1 reference

18 May 2018

Gavin Churchyard

7

1 reference

18 May 2018

Adam Penn-Nicholson

9

1 reference

18 May 2018

publication date

22 November 2017

1 reference

18 May 2018

published in

Tuberculosis

1 reference

18 May 2018

volume

109

1 reference

18 May 2018

page(s)

61-68

1 reference

18 May 2018

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Relapse, re-infection and mixed infections in tuberculosis disease

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non-Small-Cell Lung Cancer: A Review

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

The human immune response to tuberculosis and its treatment: a view from the blood

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Biomarker enrichment strategies: matching trial design to biomarker credentials

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

TB incidence in an adolescent cohort in South Africa

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Prospects for Tuberculosis Elimination

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Three months of rifapentine and isoniazid for latent tuberculosis infection

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Application of a repeat-measure biomarker measurement error model to 2 validation studies: examination of the effect of within-person variation in biomarker measurements

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Measuring the performance of markers for guiding treatment decisions

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Treatment of latent tuberculosis infection in HIV infected persons

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Clinical trial designs for predictive biomarker validation: one size does not fit all.

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Time-dependent ROC curves for censored survival data and a diagnostic marker

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Isoniazid for preventing tuberculosis in non-HIV infected persons

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

A novel blood test for tuberculosis prevention and treatment.

19 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

Prevalence of latent tuberculosis infection among gold miners in South Africa

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5884308

A novel blood test for tuberculosis prevention and treatment

30 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.11.009

Tuberculosis diagnostics: which target product profiles should be prioritised?

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.11.009

Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TUBE.2017.11.009

A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29559122

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2017.11.009

1 reference

18 May 2018

PMCID

5884308

1 reference

18 May 2018

PubMed ID

29559122

1 reference

18 May 2018